161 related articles for article (PubMed ID: 26981856)
21. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy.
Lee BS; Lee SH; Son JH; Jang DK; Chung KH; Lee YS; Paik WH; Ryu JK; Kim YT
Cancer Immunol Immunother; 2016 Feb; 65(2):141-50. PubMed ID: 26728479
[TBL] [Abstract][Full Text] [Related]
23. Prognostic effect of high pretreatment neutrophil to lymphocyte ratio on survival of patients with gastric adenocarcinoma in China.
Qiu M; Zhou Y; Jin Y; Wei XL; Wang DS; Ren C; Bai L; Yang DJ; Xu RH
Int J Biol Markers; 2015 Feb; 30(1):e96-103. PubMed ID: 25450650
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
25. Novel immunological and nutritional-based prognostic index for gastric cancer.
Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
[TBL] [Abstract][Full Text] [Related]
26. Combined Plasma Fibrinogen and Neutrophil Lymphocyte Ratio in Ovarian Cancer Prognosis May Play a Role?
Marchetti C; Romito A; Musella A; Santo G; Palaia I; Perniola G; Di Donato V; Muzii L; Benedetti Panici P
Int J Gynecol Cancer; 2018 Jun; 28(5):939-944. PubMed ID: 29538251
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy.
Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
Dig Surg; 2015; 32(6):496-503. PubMed ID: 26544755
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study.
Bozkurt O; Firat ST; Dogan E; Cosar R; Inanc M; Ozkan M
J BUON; 2019; 24(5):1992-1999. PubMed ID: 31786866
[TBL] [Abstract][Full Text] [Related]
29. [Predicting value of dynamic alteration of blood neutrophil/lymphocyte ratio on recurrence-free survival in patients with advanced colon cancer after operation and chemotherapy].
Li J; Jia YB; Cai CN; Guan XD; Li PP; Xie YY; Zhang BM
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Nov; 15(11):1171-4. PubMed ID: 23172532
[TBL] [Abstract][Full Text] [Related]
30. Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy.
Kunisaki C; Takahashi M; Ono HA; Oshima T; Takagawa R; Kimura J; Kosaka T; Makino H; Akiyama H; Endo I
Oncology; 2012; 83(4):183-91. PubMed ID: 22890015
[TBL] [Abstract][Full Text] [Related]
31. Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer.
Wang Y; Liu P; Xu Y; Zhang W; Tong L; Guo Z; Ni H
Cancer Chemother Pharmacol; 2015 Feb; 75(2):255-62. PubMed ID: 25428515
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis.
Arigami T; Okumura H; Matsumoto M; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Ishigami S; Natsugoe S
Medicine (Baltimore); 2015 Oct; 94(42):e1702. PubMed ID: 26496280
[TBL] [Abstract][Full Text] [Related]
33. Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.
Zeng YC; Chi F; Xing R; Xue M; Wu LN; Tang MY; Wu R
Jpn J Clin Oncol; 2016 Feb; 46(2):126-31. PubMed ID: 26611205
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.
Formica V; Morelli C; Ferroni P; Nardecchia A; Tesauro M; Pellicori S; Cereda V; Russo A; Riondino S; Guadagni F; Roselli M
Cancer Biomark; 2016 Sep; 17(3):335-345. PubMed ID: 27434293
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Fanotto V; Cordio S; Pasquini G; Fontanella C; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Torri V; Aprile G
Gastric Cancer; 2017 Sep; 20(5):825-833. PubMed ID: 28028664
[TBL] [Abstract][Full Text] [Related]
36. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy.
Kaneko M; Nozawa H; Sasaki K; Hongo K; Hiyoshi M; Tada N; Murono K; Nirei T; Kawai K; Sunami E; Tsuno NH; Kitayama J
Oncology; 2012; 82(5):261-8. PubMed ID: 22538399
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.
Zhang H; Zhang L; Zhu K; Shi B; Yin Y; Zhu J; Yue D; Zhang B; Wang C
PLoS One; 2015; 10(5):e0126496. PubMed ID: 25950176
[TBL] [Abstract][Full Text] [Related]
38. Differential impact of the neutrophil-lymphocyte ratio on the survival of patients with stage IV gastric cancer.
Tanaka H; Muguruma K; Toyokawa T; Kubo N; Ohira M; Hirakawa K
Dig Surg; 2014; 31(4-5):327-33. PubMed ID: 25471697
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.
Wang YY; Bai ZL; He JL; Yang Y; Zhao R; Hai P; Zhe H
Dis Markers; 2016; 2016():3740794. PubMed ID: 27087737
[TBL] [Abstract][Full Text] [Related]
40. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.
Luo G; Guo M; Liu Z; Xiao Z; Jin K; Long J; Liu L; Liu C; Xu J; Ni Q; Yu X
Ann Surg Oncol; 2015 Feb; 22(2):670-6. PubMed ID: 25155401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
